Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target refers to the mechanisms by which vaccine adjuvants enhance immune responses. Adjuvants are substances added to vaccines to improve their efficacy by stimulating the immune system through several pathways: creating a depot effect (prolonged antigen exposure), inducing cytokine production, and enhancing adaptive immunity.
Enhances magnitude/duration/type of vaccine-induced adaptive immunity through depot effect, cytokine induction, APC activation, and co-stimulatory molecule upregulation. Involves inflammasome/TLR/NOD pathway engagement, enhanced antigen presentation, recruitment/maturation/migration of APCs, and activation leading to improved naive T cell priming.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Stimulation via Depot Effect, Cytokine Induction, and Adaptive Immunity Enhancement (Adjuvants).